058820 — CMG Pharmaceutical Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩302bn
- KR₩259bn
- KR₩94bn
- 35
- 21
- 22
- 11
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 119,574 | 109,776 | 90,341 | 77,813 | 68,827 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 21,213 | 20,526 | 21,016 | 34,705 | 24,633 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 150,584 | 145,981 | 125,482 | 135,070 | 115,737 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 24,119 | 29,741 | 30,516 | 37,472 | 50,711 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 192,243 | 195,356 | 199,175 | 213,260 | 242,098 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 9,306 | 13,649 | 13,729 | 21,903 | 24,529 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 12,085 | 14,225 | 14,472 | 28,307 | 51,866 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Total Equity | 180,158 | 181,131 | 184,702 | 184,953 | 190,233 |
Total Liabilities & Shareholders' Equity | 192,243 | 195,356 | 199,175 | 213,260 | 242,098 |
Total Common Shares Outstanding |